High pretransplant parathyroid hormone levels increase the risk for graft failure after renal transplantation

被引:55
|
作者
Roodnat, Joke I.
van Gurp, Eveline A. F. J.
Mulder, Paul G. H.
van Gelder, Teun
de Rijke, Yolanda B.
de Herder, Wouter W.
Kal-van Gestel, Judith A.
Pols, Huib A. P.
Ijzermans, Jan N. M.
Weimar, Willem
机构
[1] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands
[2] Erasmus Univ, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands
[3] Erasmus MC, Dept Endocrine Lab, Rotterdam, Netherlands
[4] Erasmus MC, Dept Gen Surg, Rotterdam, Netherlands
关键词
graft survival; renal transplantation; hyperparathyroidism; parathyroid hormone; therapy compliance;
D O I
10.1097/01.tp.0000228923.75739.88
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Calcium (Ca), phosphate (P), and parathyroid hormone (PTH) are important variables influencing the risk for cardiovascular disease in dialysis patients. We studied the influence of long-standing Ca-P disregulation on renal transplant survival. Methods. Pretransplant PTH, Ca, P, total protein (TP), albumin, and alkaline phosphatase (AP) values were gathered in all 407 patients that received a renal transplant in our center between January 1, 2000 and July 1, 2004. Other variables expected to influence the risks were included. Results. In the Cox proportional hazards analysis the risk for graft failure censored for death was significantly influenced by pretransplant PTH concentration (P = 0.008) and donor type (P < 0.001). The influence of PTH on the risk for patient death was not significant. The risk for acute rejection was studied but PTH level did not have a significant influence on this risk (P = 0.055). The risk for delayed graft function was not influenced by PTH level. Conclusion. Serum PTH levels have an independent influence on the risk for graft failure censored for death. Efforts to improve calcium-phosphate-PTH homeostasis in patients on the waiting list for renal transplantation should be encouraged also to improve graft survival.
引用
收藏
页码:362 / 367
页数:6
相关论文
共 50 条
  • [41] Mycophenolate mofetil dose reduction are associated with the risk of acute rejection and graft failure after renal transplantation
    El-Agroudy, Amgad
    Alaradhi, Ali
    Farid, Eman
    Nowrooz, Mohamed
    Abdulla, Sadiq
    TRANSPLANTATION, 2016, 100 (07) : S689 - S689
  • [42] Association of elevated pretransplant sCD30 levels with graft loss in 206 patients treated with modern immunosuppressive therapies after renal transplantation
    Heinemann, Falko M.
    Rebmann, Vera
    Witzke, Oliver
    Philipp, Thomas
    Broelsch, Christoph E.
    Grosse-Wilde, Hans
    TRANSPLANTATION, 2007, 83 (06) : 706 - 711
  • [43] RENAL-TRANSPLANTATION AFTER FAILURE OF A 1ST GRAFT
    WALTZER, WC
    ZINCKE, H
    STERIOFF, S
    OFFORD, KP
    FROHNERT, PP
    SURGERY GYNECOLOGY & OBSTETRICS, 1981, 152 (04): : 476 - 482
  • [44] Elevated parathyroid hormone one year after kidney transplantation is an independent risk factor for graft loss even without hypercalcemia
    Okada, Manabu
    Tominaga, Yoshihiro
    Sato, Tetsuhiko
    Tomosugi, Toshihide
    Futamura, Kenta
    Hiramitsu, Takahisa
    Ichimori, Toshihiro
    Goto, Norihiko
    Narumi, Shunji
    Kobayashi, Takaaki
    Uchida, Kazuharu
    Watarai, Yoshihiko
    BMC NEPHROLOGY, 2022, 23 (01)
  • [45] REDUCED PHOSPHATE REABSORPTION UNRELATED TO PARATHYROID-HORMONE AFTER RENAL-TRANSPLANTATION - IMPLICATIONS FOR THE PATHOGENESIS OF HYPERPARATHYROIDISM IN CHRONIC-RENAL-FAILURE
    PARFITT, AM
    KLEEREKOPER, M
    CRUZ, C
    MINERAL AND ELECTROLYTE METABOLISM, 1986, 12 (5-6) : 356 - 362
  • [46] Elevated parathyroid hormone one year after kidney transplantation is an independent risk factor for graft loss even without hypercalcemia
    Manabu Okada
    Yoshihiro Tominaga
    Tetsuhiko Sato
    Toshihide Tomosugi
    Kenta Futamura
    Takahisa Hiramitsu
    Toshihiro Ichimori
    Norihiko Goto
    Shunji Narumi
    Takaaki Kobayashi
    Kazuharu Uchida
    Yoshihiko Watarai
    BMC Nephrology, 23
  • [47] Persistently elevated parathyroid hormone levels after parathyroid surgery
    Wang, TS
    Ostrower, ST
    Heller, KS
    SURGERY, 2005, 138 (06) : 1130 - 1135
  • [48] High parathyroid hormone levels after parathyroidectomy for parathyroid adenoma are not related to the cellularity of the remaining glands
    Sagiv, Rotem
    Delgado, Bertha
    Sadeh, Re'em
    Shashar, Sagi
    Fraenkel, Merav
    Yegodayev, Ksenia M.
    Elkabets, Moshe
    Joshua, Ben-Zion
    LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2021, 6 (05): : 1220 - 1227
  • [49] Pretransplant serum FT3 levels in kidney graft recipients are useful for identifying patients with higher risk for graft failure
    Rotondi, Mario
    Netti, Giuseppe Stefano
    Rosati, Alberto
    Mazzinghi, Benedetta
    Magri, Flavia
    Ronconi, Elisa
    Becherucci, Francesca
    Pradella, Fabio
    Salvadori, Maurizio
    Serio, Mario
    Romagnani, Paola
    Chiovato, Luca
    CLINICAL ENDOCRINOLOGY, 2008, 68 (02) : 220 - 225
  • [50] The role of intraoperative parathyroid hormone testing in patients with tertiary hyperparathyroidism after renal transplantation
    Haustein, SV
    Mack, E
    Starling, JR
    Chen, H
    SURGERY, 2005, 138 (06) : 1066 - 1071